Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
8-K
Entry into a Material Definitive Agreement
22 Mar 24
8-K
Changes in Registrant's Certifying Accountant
12 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
29 Dec 23
8-K
Departure of Directors or Certain Officers
28 Dec 23
ARS
2022 FY
Annual report to shareholders
30 Nov 23
DEF 14A
Definitive proxy
30 Nov 23
10-Q
2023 Q3
Quarterly report
15 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
2 Oct 23
424B3
Prospectus supplement
19 Sep 23
EFFECT
Notice of effectiveness
19 Sep 23
S-3/A
Shelf registration (amended)
15 Sep 23
8-K
Material Modifications to Rights of Security Holders
15 Sep 23
CORRESP
Correspondence with SEC
15 Sep 23
DEF 14A
Definitive proxy
25 Aug 23
UPLOAD
Letter from SEC
16 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
15 Aug 23
PRE 14A
Preliminary proxy
15 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
S-3
Shelf registration
11 Aug 23
D
$30.00 mm in equity / options / securities to be acquired, sold $30.00 mm, 15 investors
21 Jul 23
8-K
Petros Pharmaceuticals Announces Capital Raise of $15 million
13 Jul 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
S-8
Registration of securities for employees
22 Dec 22
8-K
Petros Pharmaceuticals Announces Reverse Stock Split
30 Nov 22
8-K
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
15 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
EFFECT
Notice of effectiveness
21 Oct 22
POS AM
Prospectus update (post-effective amendment)
14 Oct 22
DEFA14A
Additional proxy soliciting materials
12 Oct 22
DEF 14A
Definitive proxy
12 Oct 22
PRE 14A
Preliminary proxy
30 Sep 22
8-K
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
15 Aug 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
8-K
Other Events
28 Jul 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Jun 22
10-Q
2022 Q1
Quarterly report
16 May 22
Latest ownership filings
SC 13G
Ayrton Capital LLC
14 Feb 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
4
Bruce Bernstein
26 Dec 23
4
Fady Boctor
26 Dec 23
4
WAYNE REMELL WALKER
26 Dec 23
4
Mitchell Arnold
26 Dec 23
4
Joshua Silverman
26 Dec 23
4
Greg Bradley
26 Dec 23
4
Greg Bradley
28 Apr 23
4
Bruce Bernstein
28 Apr 23
4
WAYNE REMELL WALKER
28 Apr 23
4
Joshua Silverman
28 Apr 23
4
WAYNE REMELL WALKER
12 Apr 23
4
Joshua Silverman
12 Apr 23
4
Greg Bradley
12 Apr 23
4
Bruce Bernstein
12 Apr 23
SC 13G/A
INTRACOASTAL CAPITAL, LLC
8 Feb 23
4
WAYNE REMELL WALKER
25 Jan 23
4
Joshua Silverman
25 Jan 23
4
Greg Bradley
25 Jan 23
4
Bruce Bernstein
25 Jan 23
4
WAYNE REMELL WALKER
11 Apr 22
4
Joshua Silverman
11 Apr 22
4
Greg Bradley
11 Apr 22
4
Bruce Bernstein
11 Apr 22
SC 13D/A
SHULMAN JOHN D
28 Feb 22
SC 13G/A
Iroquois Capital Management, LLC
23 Feb 22
SC 13G/A
INTRACOASTAL CAPITAL, LLC
11 Feb 22
SC 13G/A
HAYWOOD GEORGE WEAVER
10 Feb 22
4
WAYNE REMELL WALKER
7 Jan 22
4
Joshua Silverman
7 Jan 22
4
Greg Bradley
7 Jan 22
4
Bruce Bernstein
7 Jan 22
4
JOHN D SHULMAN
3 Jan 22
4
JOHN D SHULMAN
30 Nov 21
SC 13G
HAYWOOD GEORGE WEAVER
27 Oct 21
SC 13G
Iroquois Capital Management, LLC
22 Oct 21
4
JOHN D SHULMAN
21 Oct 21
4
Change in insider ownership
20 Oct 21
SC 13D/A
SHULMAN JOHN D
20 Oct 21